Clinical Trials on Lipid Metabolism Disorders

Total 159802 results

Hoffmann-La Roche

Completed

A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Dyslipidemia

United States
Daewon Pharmaceutical Co., Ltd.

Unknown

Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

Dyslipidemias

Korea, Republic of
Kuhnil Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled

Dyslipidemias
National Research Council, Spain

Completed

Cardiometabolic Response to a Sodium-bicarbonated Mineral Water

Dyslipidemia
Ajinomoto Foods Europe SAS
Naturalpha; Institut Polytechnique LaSalle Beauvais

Completed

Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia (LLAX)

Dyslipidemias

France
Novartis

Completed

Fluvastatin in Adults With Dislipidemia With History of Muscle Problems

Dyslipidemia

Germany, United States
University of Miami
Humana Inc.

Completed

Improving Adherence to Statins Among Minority Populations

Dyslipidemia

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)

Dyslipidemia
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

Dyslipidemia

Korea, Republic of
Pronova BioPharma

Terminated

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States
Merck Sharp & Dohme LLC

Completed

MK0524A Bioequivalence Study (0524A-059)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

MK0524B Bioequivalence Study (0524B-070)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)

Dyslipidemia
Hospital de Clinicas de Porto Alegre

Completed

Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women

Dyslipidemia
Xention Ltd

Completed

TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) (TULIP)

Dyslipidemia

Denmark, Netherlands
University of California, San Diego
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels

Dyslipidemias

United States
China Academy of Chinese Medical Sciences

Completed

A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

Dyslipidemia
New York Hospital Queens
NYHQ Cardiac Health Center; Pivotal Therapeutics

Unknown

An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels (CARE)

Dyslipidemia

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects

Dyslipidemia

Germany
Akros Pharma Inc.

Completed

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
University of Nevada, Las Vegas

Completed

Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia

Dyslipidemia

United States
AstraZeneca

Withdrawn

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes (DEMAND)

Dyslipidemia
AstraZeneca

Completed

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria (CEPHEUS)

Dyslipidemia

Bulgaria
AstraZeneca

Completed

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (RACHEL)

Dyslipidemias
University of Washington
Upsher-Smith Laboratories

Completed

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Leiden University Medical Center
Dutch Diabetes Research Foundation

Completed

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans

Insulin Resistance | Dyslipidemia

Netherlands
University of Salerno

Not yet recruiting

Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients (BESAFE)

Cardiovascular Diseases | Dyslipidemias | Lipid Metabolism Disorders | Statin Adverse Reaction
Stanley Dudrick's Memorial Hospital

Completed

High Dose Intravenous Fish Oil Reduces Inflammation

Lipid Metabolism Disorders

Poland
Monash University Malaysia

Recruiting

Can Mindful Eating Improve Cholesterol and Glucose Level

Cholesterol; Lipidosis

Malaysia
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Academisch...

Recruiting

Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes

Insulin Resistance | Hypertriglyceridemia

Netherlands
Radiant Research

Completed

Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy (CERTAIN)

Hyperglycemia | Dyslipidemia | Hyperlipidemia

United States
University of Pavia
Foundation IRCCS San Matteo Hospital

Recruiting

Effect of the Association of Berberine Fitosoma® and Monacolin K MonaKoPure® on Glyco-metabolic Parameters in Dysglycemic and Dyslipidemic Patients.

Dyslipidemias | Dysglycemia

Italy
Arrowhead Pharmaceuticals

Not yet recruiting

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (MUIR-3)

Hypertriglyceridemia
Federico II University

Recruiting

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy (CHOLINET)

Hypercholesterolemia

Italy
Valbiotis

Recruiting

Effect of the Food Supplement TOTUM-070 on Lipid Metabolism (HEARTII)

Hypercholesterolemia

Germany
Suzhou Sanegene Bio Inc.

Not yet recruiting

A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Hyperlipidemias
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401

Hyperlipidemia

China
Kowa Company, Ltd.

Recruiting

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance

Hypercholesterolemia

Japan
Marea Therapeutics

Recruiting

Study of MAR001 in Adults With Metabolic Dysfunction

Hypertriglyceridemia

Australia
SunWay Biotech Co., LTD.

Not yet recruiting

Effect of ANKASCIN 568-P Products Regulating Blood Lipid

Hyperlipidemias
Federico II University

Recruiting

Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy (AT-TARGET-IT)

Hypercholesterolemia

Italy
Assistance Publique Hopitaux De Marseille

Recruiting

Role of A2A Receptor in Hypercholesterolemic Patients (RASCAS)

Hypercholesterolemia

France
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia

Hypercholesterolemia

China
Response Pharmaceuticals

Completed

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

Hypertriglyceridemia

Germany
Vaxxinity, Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants

Hypercholesterolemia

Australia
University of Jordan

Completed

Comparison of the Effect of MCFA and LCFA on Postprandial Appetite and Lipemia

Lipemia

Jordan
Walter Reed National Military Medical Center

Completed

Effect of Butter & MCT Oil on Lipoproteins - A RCT

Hyperlipidemia

United States

3

Subscribe